Diabetes, Vol 46, Issue 6 978-982, Copyright © 1997 by American Diabetes Association

ARTICLES

Proinsulin conversion in GH3 cells after coexpression of human proinsulin with the endoproteases PC2 and/or PC3

JE Kaufmann, JC Irminger, J Mungall and PA Halban
Louis Jeantet Research Laboratories, University Medical Centre, Geneva, Switzerland.

Proinsulin conversion to insulin occurs in secretory granules of pancreatic beta-cells. This processing has been suggested to require both the endoproteases PC2 and PC3 with each cleaving at only one of the two sites linking the insulin A- and B-chains with C-peptide. To evaluate this in an appropriate cellular setting, conversion of human proinsulin was followed in GH3 (rat pituitary) cells normally unable to convert this prohormone but equipped with the regulated secretory pathway. For this purpose, human proinsulin was expressed in GH3 cells, alone or in combination with PC2 and/or PC3, using recombinant adenoviruses. Cells were infected with the given adenoviruses and 24 h later were pulse-chased. Kinetics of proinsulin conversion were monitored by reverse-phase high-performance liquid chromatography. It was observed that while the two endoproteases do display a preference for a single site of cleavage (PC2 at the A-chain/C-peptide junction; PC3 at the B-chain/C-peptide junction) and act in a synergistic manner to promote proinsulin conversion, either PC2 or PC3 alone can cleave at both sites to fully convert proinsulin to insulin. These results also show that a cell can be successfully infected by three different recombinant adenoviruses.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				L. Marzban, C. J. Rhodes, D. F. Steiner, L. Haataja, P. A. Halban, and C. B. Verchere Impaired NH2-Terminal Processing of Human Proislet Amyloid Polypeptide by the Prohormone Convertase PC2 Leads to Amyloid Formation and Cell Death. Diabetes, August 1, 2006; 55(8): 2192 - 2201. [Abstract] [Full Text] [PDF]

				R. Ugleholdt, M.-L. H. Poulsen, P. J. Holst, J.-C. Irminger, C. Orskov, J. Pedersen, M. M. Rosenkilde, X. Zhu, D. F. Steiner, and J. J. Holst Prohormone Convertase 1/3 Is Essential for Processing of the Glucose-dependent Insulinotropic Polypeptide Precursor J. Biol. Chem., April 21, 2006; 281(16): 11050 - 11057. [Abstract] [Full Text] [PDF]

				Y. L. Zhu, A. Abdo, J. F. Gesmonde, K. C. Zawalich, W. Zawalich, and P. S. Dannies Aggregation and Lack of Secretion of Most Newly Synthesized Proinsulin in Non-{beta}-Cell Lines Endocrinology, August 1, 2004; 145(8): 3840 - 3849. [Abstract] [Full Text] [PDF]

				L. Marzban, G. Trigo-Gonzalez, X. Zhu, C. J. Rhodes, P. A. Halban, D. F. Steiner, and C. B. Verchere Role of {beta}-Cell Prohormone Convertase (PC)1/3 in Processing of Pro-Islet Amyloid Polypeptide Diabetes, January 1, 2004; 53(1): 141 - 148. [Abstract] [Full Text] [PDF]

				J. Wang, J. Xu, J. Finnerty, M. Furuta, D. F. Steiner, and C. B. Verchere The Prohormone Convertase Enzyme 2 (PC2) Is Essential for Processing Pro-Islet Amyloid Polypeptide at the NH2-Terminal Cleavage Site Diabetes, March 1, 2001; 50(3): 534 - 539. [Abstract] [Full Text]

				R. Kuliawat, D. Prabakaran, and P. Arvan Proinsulin Endoproteolysis Confers Enhanced Targeting of Processed Insulin to the Regulated Secretory Pathway Mol. Biol. Cell, June 1, 2000; 11(6): 1959 - 1972. [Abstract] [Full Text]

				C. Rosnoblet, U. M. Vischer, R. D. Gerard, J.-C. Irminger, P. A. Halban, and E. K. O. Kruithof Storage of Tissue-Type Plasminogen Activator in Weibel-Palade Bodies of Human Endothelial Cells Arterioscler. Thromb. Vasc. Biol., July 1, 1999; 19(7): 1796 - 1803. [Abstract] [Full Text] [PDF]

				M. Furuta, R. Carroll, S. Martin, H. H. Swift, M. Ravazzola, L. Orci, and D. F. Steiner Incomplete Processing of Proinsulin to Insulin Accompanied by Elevation of Des-31,32 Proinsulin Intermediates in Islets of Mice Lacking Active PC2 J. Biol. Chem., February 6, 1998; 273(6): 3431 - 3437. [Abstract] [Full Text] [PDF]